To explore the regulatory effects of HINT2 in the next stages of MASLD, we induced a metabolic dysfunction-associated steatohepatitis (MASH) mouse model using WD + SW (Fig. 4a). The gene discussed is HINT2; the disease is metabolic dysfunction-associated steatotic liver disease.